(Z)-1-chloro-2-phenyl-1-butene | 78463-03-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (Z)-1-chloro-2-phenyl-1-butene
• 英文别名: [(Z)-1-chlorobut-1-en-2-yl]benzene
• CAS: 78463-03-3
• 化学式: C₁₀H₁₁Cl
• 分子量: 166.65
• InChiKey: TYKCWZDXOSAORJ-HJWRWDBZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为产物：
  描述：

  (E)-trimethyl(2-phenylbut-1-en-1-yl)silane 在 盐酸 、 三氟化硼乙醚 、 间氯过氧苯甲酸 作用下， 以 乙醚 、 二氯甲烷 为溶剂， 反应 12.5h， 生成 (Z)-1-chloro-2-phenyl-1-butene
  参考文献：
  名称：

  Regiospecific and stereospecific synthesis of E- and Z-trisubstituted alkenes via 2,2-disubstituted vinylsilanes

  摘要：

  DOI：

  10.1021/jo00265a028

文献信息

• Method for Producing an Anion-Exchange Membrane for a Solid Polymer Electrolyte Type Fuel Cell
  申请人：Fukuta Kenji

  公开号：US20110207028A1

  公开（公告）日：2011-08-25

  An anion-exchange membrane having quaternary ammonium groups or quaternary phosphonium groups wherein halogen ions serve as the counter ions is obtained. Rather than being subjected to ion exchange with an OH-type membrane using a toxic substance such as sodium hydroxide, the halogen-type anion exchange membrane is brought into contact with a carbonate solution and/or bicarbonate solution to directly obtain an anion exchange membrane where at least some of the counterions of the quaternary ammonium groups or quaternary phosphonium groups are CO 3 2− and/or HCO 3 − .

  获得了具有季铵基或季膦基的阴离子交换膜，其中卤素离子作为对离子。与使用像氢氧化钠这样的有毒物质对OH型膜进行离子交换不同，卤素型阴离子交换膜与碳酸盐溶液和/或碳酸氢盐溶液接触，直接获得至少一些季铵基或季膦基的对离子为CO32−和/或HCO3−的阴离子交换膜。
• SUBSTITUTED 3-HALOALLYLAMINE INHIBITORS OF ASSAO AND USES THEREOF
  申请人：Pharmaxis Ltd.

  公开号：US20150158813A1

  公开（公告）日：2015-06-11

  The preparation and pharmaceutical use of substituted 3-haloallylamine derivatives as SSAO/VAP-1 inhibitors having the structure of Formula I: is described. Methods of using compounds of Formula I, or pharmaceutically acceptable salt or derivatives thereof, for the treatment of a variety of indications, e.g., inflammatory diseases, ocular diseases, fibrotic diseases, diabetes-induced diseases and cancer, are also described.

  本文描述了替代的3-卤代烯丙胺衍生物的制备和制药用途，作为具有公式I结构的SSAO/VAP-1抑制剂。还描述了使用公式I化合物或其药学上可接受的盐或衍生物治疗各种疾病的方法，例如炎症性疾病、眼部疾病、纤维化疾病、糖尿病诱导的疾病和癌症。
• Electrorheological fluids
  申请人：NIPPON SHOKUBAI KAGAKU KOGYO CO. LTD.

  公开号：EP0523300A1

  公开（公告）日：1993-01-20

  An electrorheological fluid composition comprising a dispersion of disperse-phase particles formed of a sulfonated polymer possessing aromatic rings substituted with sulfonic acid groups in an electrically non-conducting oil which electrorheological fluid is characterized by the fact that the number of sulfonic acid groups in said sulfonated polymer forming said disperse-phase particles exceeds the number of aromatic rings present in said sulfonated polymer.

  一种电流变液组合物，包含由磺化聚合物形成的分散相颗粒的分散体，该磺化聚合物具有被磺酸基团取代的芳香环，分散在不导电的油中，该电流变液的特点是形成所述分散相颗粒的所述磺化聚合物中磺酸基团的数量超过所述磺化聚合物中芳香环的数量。
• Axelrad, George; Laosooksathit, Surin; Engel, Robert, Synthetic Communications, 1981, vol. 11, # 5, p. 405 - 408
  作者：Axelrad, George、Laosooksathit, Surin、Engel, Robert

  DOI：——

  日期：——
• CHOU, SHANG-SHING P.;KUO, HWEI-LON;WANG, CHUNG-JEN;TSAI, CHUNG-YING;SUN, +, J. ORG. CHEM., 54,(1989) N, C. 868-872
  作者：CHOU, SHANG-SHING P.、KUO, HWEI-LON、WANG, CHUNG-JEN、TSAI, CHUNG-YING、SUN, +

  DOI：——

  日期：——